StockNews.com initiated coverage on shares of Athersys (NASDAQ:ATHX – Get Free Report) in a research report issued to clients and investors on Saturday. The firm set a “hold” rating on the biopharmaceutical company’s stock.
Athersys Price Performance
Athersys has a 12-month low of $0.01 and a 12-month high of $1.99. The stock has a market capitalization of $833,000.00, a P/E ratio of -0.01 and a beta of -0.90.
About Athersys
Want More Great Investing Ideas?
Featured Articles
- Five stocks we like better than Athersys
- What is the FTSE 100 index?
- The Outlook for Interest Rate Cuts Got Blown Out of the Water
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- 3 High-Risk, High-Reward Micro-Cap Stocks You Shouldn’t Ignore
- Utilities Stocks Explained – How and Why to Invest in Utilities
- 3 Bargain Stocks Positioned for Gains After Missing 2024’s Rally
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.